Pharmagenomics Drug Discovery In the Post Genomic Era Trademark Details

Pharmagenomics Drug Discovery in the Post Genomic Era was registered on Tuesday, February 4, 2003 and is currently owned by Advanstar Communications Inc. under the registration number 2684949 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 14 years ago on Saturday, September 12, 2009, according to the United State Patent & Trademark Office
Word Mark Pharmagenomics Drug Discovery in the Post Genomic Era
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Advanstar Communications Inc. of Duluth, MN

View all trademarks for Advanstar Communications Inc.
Other Trademarks for Advanstar Communications Inc.
Serial Number 76362087
Registration Number 2684949
Status Date Saturday, September 12, 2009
Filing Date Saturday, September 12, 2009
Registration Date Tuesday, February 4, 2003
Attorney Martha M Markusen

Correspondent

MARTHA M MARKUSEN
FRYBERGER BUCHANAN SMITH & FREDERICK PA
700 LONSDALE BLDG
302 W SUPERIOR ST
DULUTH MN 55802-1863

Case File Statements

Goods & Services Trade Magazine for Pharmaceutical Scientists in the Field of Drug Discovery, Genomics and Proteomics

Classifications

International Class Codes
016 — Class 16 includes mainly paper, goods made from that material and office requisites.
U.S. Class Codes 002, 005, 022, 023, 029, 037, 038, 050
Status 2 — Sec. 8 – Entire Registration
Status Date Saturday, September 12, 2009
First Use Anywhere Tuesday, January 1, 2002
First Use In Commerce Tuesday, January 1, 2002
Primary Code 016

You must be signed in to print.

Once signed in, look for the PDF button.